ADAM9 and cancer: More importantly, CM derived from bladder, duodenum, colorectal, and esophageal cancer cell lines efficiently cleaved the ADAM9-substrate—indeed indicating that our ADAM9-MSN platform might be applicable to multiple types of cancer.